This meeting was designed to offer a place to exchange the latest information on into the development of narcolepsy following vaccination with one of the 2009 adjuvanted influenza A(H1N1) vaccines.
Location:Geneva, Switzerland
Organized by:International Alliance for Biological Standardisation and the World Health Organization
Joint Meeting of the EFSA Animal Health and Welfare Network and the ECDC Emerging and Vector-borne Disease Network on West Nile fever virus surveillance in the European Union
WHO/Europe has been holding annual influenza surveillance meetings jointly with the European Centre for Disease Prevention and Control (ECDC) since 2011. This meeting brought together epidemiologists and virologists – the national influenza surveillance focal points – from 50 Member States to discuss national, regional and global surveillance related to seasonal influenza and novel influenza viruses, such as avian influenza A(H7N9).
The objective for this meeting between ECDC and influenza vaccine manufacturers was to share latest information on influenza disease monitoring including severe disease, monitoring of seasonal influenza vaccination programmes in the EU and new technical developments for improved influenza vaccines.
The third annual joint influenza surveillance meeting was held in Istanbul. The meeting focused on virological and epidemiological aspects of influenza surveillance, influenza vaccination, and new developments in the field of influenza prevention and control.